1. Katoh, Masaru. . WNT3-WNT14B and WNT3A-WNT14 gene clusters (Review). In International journal of molecular medicine, 9, 579-84. doi:. https://pubmed.ncbi.nlm.nih.gov/12011973/
2. Nakashima, Nariyasu, Liu, Dage, Huang, Cheng-Long, Zhang, Xia, Yokomise, Hiroyasu. 2011. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. In Lung cancer (Amsterdam, Netherlands), 76, 228-34. doi:10.1016/j.lungcan.2011.10.007. https://pubmed.ncbi.nlm.nih.gov/22070884/
3. Eiraku, Mototsugu, Watanabe, Kiichi, Matsuo-Takasaki, Mami, Muguruma, Keiko, Sasai, Yoshiki. . Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. In Cell stem cell, 3, 519-32. doi:10.1016/j.stem.2008.09.002. https://pubmed.ncbi.nlm.nih.gov/18983967/
4. Katoh, Masaru. . Comparative genomics on Wnt3-Wnt9b gene cluster. In International journal of molecular medicine, 15, 743-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15754041/
5. Wang, Bing-Qian, Gao, Shu-Tao, Chen, Kun, Xia, Yun, Lv, Zheng-Tao. 2018. Association of the WNT3 polymorphisms and non-syndromic cleft lip with or without cleft palate: evidence from a meta-analysis. In Bioscience reports, 38, . doi:10.1042/BSR20181676. https://pubmed.ncbi.nlm.nih.gov/30355643/
6. Lu, Y P, Han, W T, Liu, Q, Jiang, M, Xu, W. 2015. Variations in WNT3 gene are associated with incidence of non-syndromic cleft lip with or without cleft palate in a northeast Chinese population. In Genetics and molecular research : GMR, 14, 12646-53. doi:10.4238/2015.October.19.8. https://pubmed.ncbi.nlm.nih.gov/26505415/
7. Zhang, Linlin, Sang, Min, Li, Ying, Yang, Peifeng, Yuan, Enwu. 2021. WNT3 hypomethylation counteracts low activity of the Wnt signaling pathway in the placenta of preeclampsia. In Cellular and molecular life sciences : CMLS, 78, 6995-7008. doi:10.1007/s00018-021-03941-4. https://pubmed.ncbi.nlm.nih.gov/34608506/
8. Zhang, Xuyang, Sun, Kairui, Gan, Ruihuan, Zheng, Dali, Lu, Youguang. 2024. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. In BMC cancer, 24, 564. doi:10.1186/s12885-024-12318-2. https://pubmed.ncbi.nlm.nih.gov/38711026/